Revolution Medicines Inc (RVMD) Price Prediction & ForecastRVMDRevolution Medicines Inc

Alphio's RVMD stock price prediction model matches the current Revolution Medicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $177.02 (-0.53%). The 1-week path is $188.50 (+5.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Revolution Medicines Inc is currently trading at $177.96, which is significantly below the average analyst price target of $259, indicating a potential upside of 45.5%. However, the stock has a low RSI of 24.81, suggesting it is oversold, and it has experienced a 6.22% decline over the past five days. While the recent approval of Rasonque for metastatic pancreatic cancer could drive future growth, the company is facing substantial net losses, with a projected net income of -$644 million in Q2 2026. Therefore, while there is potential for recovery, the high volatility and ongoing losses suggest a cautious approach is warranted.

Revolution Medicines Inc (RVMD) last closed at $177.96, losing -5.97%. These facts feed the 1-day and 1-week RVMD price prediction above.